A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations

NCT07414290 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease (PD)

Interventions

DRUG: VGN-R08b 4.2×10^13 vg
DRUG: VGN-R08b 8.4×10^13 vg
DRUG: VGN-R08b 1.68×10^14 vg

Sponsor

Shanghai Vitalgen BioPharma Co., Ltd.